Lpar1tm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Lpar1tm1d(EUCOMM)Wtsi |
Name: |
lysophosphatidic acid receptor 1; targeted mutation 1d, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6119422 |
Gene: |
Lpar1 Location: Chr4:58435255-58553898 bp, - strand Genetic Position: Chr4, 32.2 cM
|
Alliance: |
Lpar1tm1d(EUCOMM)Wtsi page
|
IMPC: |
Lpar1 gene page |
|
Germline Transmission: |
Earliest citation of germline transmission:
J:204812
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 58486214 of Chromosome 4 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 58486214. The critical exon(s) is/are thus flanked by loxP sites. A null/knockout allele was created by flp and cre recombinase expression in mice carrying this allele to remove the lacZ sequence, neo selection cassette and the loxP-flanked critical exon(s).
(J:155845)
|
|
|
|
Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
All: |
2 reference(s) |
|